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Abstract
Background: Human height is a complex trait with a strong genetic basis. Recently, a significant association
between rare copy number variations (CNVs) and short stature has been identified, and candidate genes in these
rare CNVs are being explored. This study aims to evaluate the association between mutations in ARID1B gene and
short stature, both the syndromic and non-syndromic form.
Results: Based on a case-control study of whole genome chromosome microarray analysis (CMA), three
overlapping CNVs were identified in patients with developmental disorders who exhibited short stature. ARID1B, a
causal gene for Coffin Siris syndrome, is the only gene encompassed by all three CNVs. A following retrospective
genotype-phenotype analysis based on a literature review confirmed that short stature is a frequent feature in
those Coffin-Siris syndrome patients with ARID1B mutations. Mutation screening of ARID1B coding regions was
further conducted in a cohort of 48 non-syndromic short stature patients,andfour novel missense variants including
two de novo mutations were found.
Conclusion: These results suggest that haploinsufficient mutations of ARID1B are associated with syndromic short
stature including Coffin-Siris syndrome and intellectual disability, while rare missense variants in ARID1B are
associated with non-syndromic short stature. This study supports the notion that mutations in genes related to
syndromic short stature may exert milder effect and contribute to short stature in the general population.
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Background
Human height is a quantitative trait that follows a
Gaussian distribution. Short stature is typically defined
as a height more than 2 standard deviations (SD) below
the corresponding mean height for a given age, gender
and ethnic population. Individuals with short stature in-
clude those at the tail of the normal distribution (not
necessary associated with any disorders) as well as in-
dividuals with rare disorders that restrict growth.
Genome-wide association studies (GWAS) have identified
over 400 independent loci associated with height in the
general population which collectively explain ~20 % of the
variation in adult height [1]. Rare variants with larger
effects have been found in a number of genes leading to
syndromic short stature disorders. For example, the SHOX
gene was identified as the gene responsible for short stat-
ure in Turner syndrome [2] and Leri-Weill syndrome [3].
Recently, we demonstrated a significant association be-
tween low-frequent copy number deletions and short stat-
ure, supporting the hypothesis that rare haploinsufficient
genes play significant roles in human growth [4]. We fur-
ther demonstrated that an increased burden of rare
deletions may also contribute to short stature in a non-
clinically ascertained population, underscoring the concept
that milder defects in genes known to cause syndromic
short stature may contribute to short stature in the general
population.
In this study, we focus on a recurrent CNV detected
in patients with short stature. We propose that the
ARID1B gene, which is the only gene intercepted by
three CNVs, is a novel short stature gene. We provide
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additional evidence supporting that ARID1B mutations
are associated with both syndromic and non-syndromic
short stature.
Methods
CNV detection and evaluation
Whole genome microarray (Agilent 244K) was per-
formed to detect structural variants in a clinical cohort.
Subjects were eligible if they had a height measurement
recorded between the ages of 2 and 20 years and had a
chromosomal microarray performed as part of their
clinical evaluation. All information was obtained with
appropriate consent from Boston Children’s hospital
[M09-06-0290]. Subjects with aneuploidy and poor
microarray quality were not included, leaving a final
sample size of 4,411 individuals including 415 patients
with short stature, 196 patients with tall stature and
3800 patients with normal stature. All CNV data were
called with NEXUS software (BioDiscovery, El Segundo,
California). The recurrent copy-number variations in-
volving ARID1B gene were validated by multiplex
ligation-dependent probe amplification (MLPA). MLPA
probe and reagents from MRC Holland (SALSA MLPA
P433 ARID1A-ARID1B probemix). Data analysis and
visualization was done on Coffalyzer software. A CNV
is defined as non-benign when it does not overlap with
CNV reported in DGV (Database of Genomic variants)
or overlaps with CNV with less than 1 % population fre-
quency in DGV. Non-benign recurrent or overlapping
CNVs were identified in the subjects with short stature
and compared to their occurrence in normal stature
population. The UCSC genome browser’s custom track
was used to depict the overlapping nature of CNVs and to
delineate the minimal region of overlap (MRO).
Literature review of height of patients with ARID1B
deletion or mutation
We identified a total of 70 individuals carrying ARID1B
deletions or mutations from a Pubmed search and the
DECIPHER database. 65 of them had information on
height. We converted all height parameters available to Z-
scores based on CDC growth charts (http://www.cdc.gov/
growthcharts/zscore.htm).
Mutation screening in 48 non-syndromic short stature
Chinese patients
Forty-eight non-syndromic short stature Chinese patients
were recruited in Shanghai Children’s Medical Center.
Their age, gender and height information are included in
Additional file 1. The inclusion criteria were individuals
with height below 3rd percentile without a clinical diag-
nosis of intellectual disability or developmental delay.
All information was obtained with appropriate consent
based on requirements of Shanghai Children’s Medical
Center【SCMC-IRB-K2013007】.Subjects were randomly
selected in non-syndromic short stature patients. Since it
is unclear yet if ARID1B affects hormone-related path-
ways, we did not use hormonal status as a criteria for
subject selection. Genomic DNA was extracted from
peripheral blood of all participants using QIAamp
Blood DNA Mini kit®. Mutation screening for all cod-
ing regions of ARID1B were done by Polymerase chain
reaction (PCR) amplification followed by Sanger se-
quencing. Sequence variants were evaluated with mu-
tation surveyor (Soft Genetics, State College, PA) and
their potential functional impact was predicted using
insilico prediction programs including SIFT [5], Poly-
phen2 [6], Condel [7] and Align-GVGD [8]. Paternity
tests were performed with short tandem repeat (STR)
markers for the two probands with de novo variants
(using AmpFLSTR® Identifiler® PCR amplification kit).
The study was reviewed and approved by the SCMC
ethical committee and all participants or their parents
signed an informed consent form. In addition, we com-
pared the variant frequency in the ARID1B coding
regions detected by exome sequencing to that of 494
normal Chinese controls. The normal Chinese controls
were age and gender matching Chinese individuals of
normal height, weight and were recruited from multiple
geographic areas for an effort to create a common
sequence variants database of normal Chinese children.
Results
Copy number imbalances involving ARID1Bin patients
with short stature and developmental disorder
Four thousand four hundred eleven individuals in the
clinical population met our inclusion criteria (as described
in methods), including 415 patients with short stature,
196 patients with tall stature and 3800 patients with
normal stature. Three individuals with copy number
variants encompassing ARID1B were identified among
415 patients with short stature who underwent clinical
microarray analysis at Boston Children’s Hospital. The
locations of the two deletions and one duplication in
relation to the ARID1B gene are shown in Fig. 1.
Figure 1
Red tracks indicate deletion and blue track indicates
duplication. The numbers associated with each track are
the Z-scores of patient’s height.
The first patient (patient A) carries a 658 kb de novo
deletion at 6q25.3 which affected only ARID1B; the
second patient (patient B) carries a 6.8 Mb de novo
deletion at 6q25.1-q25.3 which overlaps with the dele-
tion in Patient 1. The height Z-score for both patients
are -2.3 and -2.1 respectively. The patient with the dupli-
cation (patient C) was a 13-year-old Caucasian girl who
carries a 207 Kb maternally inherited intragenic duplication
at 6q25.3. Her height Z-score was -2.7. The mother’s height
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is below average (Z = -0.33) but not short. In addition to
short stature, all three patients exhibited language impair-
ment, facial malformation and intellectual disability. Thus
all three patients exhibited syndromic short stature.
Detailed clinical phenotypes and their growth curves
can be found in Additional files 1 & 2.
There were no CNVs involving ARID1B in 3800
patients with normal stature and 196 patients with tall
stature in our clinical population.
Short stature is a frequent feature associated with
patients with ARID1B mutations
A total of 70 patients with mutations in ARID1B (includ-
ing translocation, deletion, duplication, nonsense and
truncating mutations) have been described in the litera-
ture and Decipher database, many of whom have Coffin-
Siris syndrome. We summarize the available clinical
features of these patients in Table 1. Five patients had no
height information. 22 out of the remaining 65 patients
(33.8 %) had short stature. 90 % of patients have height Z-
scores below -1 SD. None of the patients had height Z-
scores above 0 SD. The average available Z score among
patients with mutations in ARID1B is -1.86 SD. Thus,
growth retardation and short stature is a common feature
associated with mutations in ARID1B and Coffin-Siris
syndrome.
ARID1B mutations in non-syndromic patients with short
stature
We sequenced the coding regions and intron-exon
boundaries of ARID1B in 48 non-syndromic short stature
Chinese patients. We detected four missense variants
(Fig. 2). Variants c.2351C > T and c.4727C > T in patients
D and E respectively were inherited from their fathers and
the c.2351 variant was present in a sister of normal height
as well. Variants c.4346G >C and c.5998G > T in patients
F and G were not identified in either parent. Paternity test
confirmed the biological relationship between the pro-
bands and their parents (data available in Additional
file 3), thus these two missense variants are de novo
changes in the probands. Provocative growth hormone
(GH) testing with intravenous infusion of Arginine and
oral administration of clonidine was performed in the
patients, following routine procedures. Patient E, F and
G exhibited partial growth hormone deficiency by pro-
vocative GH testing (5-7ng/ml).Patient D had a normal
growth hormone level (15.272ng/ml). None of them had
intellectual disability or language impairment. Thus they
are all considered to have non-syndromic short stature.
Detailed clinical information of the four patients is pre-
sented in Additional file 1.
The four missense variants were all predicted to be
deleterious by SIFT, PolyPhen2 and Condel (Additional
file 4). They were novel variants and absent from 494
Chinese controls, the NHLBI Exome Variant Server
6500 dataset (http://evs.gs.washington.edu/EVS/) and
the ExAC database (http://exac.broadinstitute.org/).
We detected 8 novel variants predicted to be deleteri-
ous in 494 Chinese controls. There is a significant en-
richment of novel deleterious missense variants
detected in short stature patients when compared to
the normal Chinese controls (p = 0.016 Fisher exact
test). It is unclear if the inherited variants in Patients D
and E are pathogenic given the lack of segregation with
short stature in the family. Partial penetrance of these
two inherited variants are possible. Based on the re-
cently published guideline for variant interpretation [9],
the two de novo variants are classified as likely patho-
genic and the other two variants are of uncertain sig-
nificance (see Additional file 4).
Discussion
High resolution array CGH enables the detection of
small CNVs involving one gene or part of a gene. This
approach allowed for the identification of candidate
short stature genes. We scanned the whole genome for
single CNVs in individual patients or overlapping CNVs
with a single gene in the region of overlap in patients
with short stature. We paid particular attention to de
novo CNVs only present in patients and not in a control
population. By this approach, we identified a chromatin-
remodeling gene ARID1B as a novel short stature gene.
Fig. 1 Three individuals with copy number variants encompassing ARID1B shown as tracks in the UCSC genome browser
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Table 1 Clinical features of patients with ARID1B mutations
Cases from literature review
Case IDa 1 2 3 4 5 6 7 8 9 10 11 12
Gender M F M F F F F F F F M M
Genomic defectb Trans Del Del Del Del Del Del Del Del Dup Nonsense Fx
Height (age) 117 cm
(7.5 y)
84 cm







152 cm (18 y) 124 cm




(3 y 3 m)
3–10th
(4 y 11 m)
3-10th
(3 y 5 m)
<3rd
(7 y 3 m)
Z-score −1.8 −2.5 −3.5 <−2.0 −2 −1.65 −2 −4 −1.2 −1.5 −1.5 −2
OFC (age) +1.4 SD −0.7 SD −0.75 SD NA Z=0 25–50th Z=0 −2.5 SD 10–25th <3rd 50th 25–50th
DD/ID + + + + + + + + + + + +
ACC + NA NA NA Partial Partial + + + NA
Hypotonia + + NS + + + + + + + + +
Seizure NS + + +
ASD + + + + NS + +
Language impairment + + + + + + + + + + + +
Malformation
Coarse facial NS NS + NS NS NS NS NS NS NS NS NS
Low hair line + NS NS + NS + + + NS NS NS NS
Hypertrichosis + NS NS NS NS + +
Ear + NS + NS NS NS NS + + + + +
Eye + NS + + + + + + + + + +
Nose + NS + + NS + NS + + + NS +
Mouth/lips/palate + + + + + + + NS + + +
Skeletal NS + + NS NS + NS + NS + NS NS
Limb/extremeties + + + + + + + + NS + + +
Cases from literature review
Case ID 53 54 55 56 57 58 59 60 61 62 63 64
Gender M F M M M M M M M F 0 0
Genomic defect Del Del Del Del Del Del Del Fx Nonsense Nonsense Fx Del
Height (age) 69.5 cm (10 m) 66 cm (9 m) 63.5 cm (7 m) 162 cm (16 y 6 m) 47 cm (14 days) 55.5 cm (at birth) 46.6 cm (3 m) 2/5 has short stature
Z-score −1.56 −2.0 −2.0 −1.7 <−1.65 −1.65 <−3.0
OFC (age) Z=−4.5 Z=0 Z<−2.0 53 cm Z<−1.65 Z=1.65 Z<−3.0 NS NS NS NS NS
DD/ID + + + + + + + + + + + +
ACC + + NS NS + NS + NS NS NS NS NS













Table 1 Clinical features of patients with ARID1B mutations (Continued)
Seizure NS NS NS + NS NS NS 2/5 have seizure
ASD NS NS NS + NA NA NA NS NS NS NS NS
Language impairment NS NS NS + NS NS NS NS NS NS NS NS
Malformation
Coarse facial + + NS NS NS + + + + + +
Low hair line NS NS NS NS NS NS NS NS NS NS NS NS
Hypertrichosis NS NS NS NS + NS NS + + + + +
Ear + + NS + + + + 4/5 have abnormal ears
Eye + + + + + + + 1/5 with vision problem
Nose + NS + + + + + + + + + +
Mouth/lips/palate + + + + NS NS + + + + + +
Skeletal NS NS NS NS NS NS NS 3/4 have spinal anomalies













Cases from literature review
13 14 15 16 17 18~45 46 47 48 49 50 51 52
F F F M M NS F M F M M F F
Nonsense Fx Fx Nonsense Fx Del Del Del Del Del Del Del
<3rd (12 y 8 m) 10–25th
(4 y)
25–50th







NS NS NS 52 cm
(50th )
89.2 cm





−2 −1.2 −0.6 0 −2 −1.5 −3.5 −2.6 0 −1.34 −1.65 −2.7
25–50th 75th 75th >97th <3rd 0 % (0/27) <−2.5SD NS Z=−0.75 NS 75th 46.2 cm 31 cm Z=−4.3
+ + + + + 89 % (25/28) + + + + + + +
NA + NA 36 % (9/25) NS NS + NS NS +
+ + + 85 % (23/27) NS NS NS + NS + NS
+ + + 20 % (5/20) NS NS NS NS NS + NS
NS NS NS NS NS NS NS NS
+ + + + + 100 % (28/28) + + + + NS + +
Malformation
NS NS NS NS NS NS + + NS + + +
NS NS NS NS NS 64 % (18/28) + NS NS NS NS
+ + 93 % (26/28) NS NS NS NS
+ + + + + 50 % (14/28) NS NS NS + + + +
+ + NS + NS 65 % (17/26) + + + + + + +
+ + + NS NS 52 % (14/27) NS NS NS + + + +
+ + + NS + 78 % (21/27) NS NS NS + + + +
NS NS NS NS + 17 % (2/12) NS NS NS NS NS NS NS
+ + NS NS + >75 % + NS NS + NS NS +
Cases from decipher database Our cases from microarray and sequence
65 66 67 68 69 70 A B C D E F G
M F F NS NS M M M F M M F F
Del Del Del Del Del Dup Del Del Dup Missense Missense Missense Missense
Short stature NS NS NS NS NS <3rd 3rd −3 SD
(12 y 8 m)
−3 SD
(3 y 6 m)
−3 SD
(3 y 2 m)
−2 SD
(9 y 8 m)
−2 SD
(8 y 9 m)
−2 NS NS NS NS NS −2.3 −2.1 −2.7 −2 −2 −2 −2
NA NS NS NA 50th 2nd 98th NS NS NS NS
+ + + + + + + + +
NA + NS NS NS NS + + NS NS NS NS













Table 1 Clinical features of patients with ARID1B mutations (Continued)
NA + NS NS NS NS + + +
NA NS NS NS NS + +
+ NS NS NS + NS +
+ NS NS NS + NS + + +
Malformation
+ NS NS NS + NS + +
+ NS NS NS NS NS + +
NS NS NS NS + NS +
NS NS + + NS NS + + NS
+ NS + + NS NS + + +
+ NS NS NS NS NS + + NS
+ NS NS NS NS + + + +
NS NS NS NS NS + + + +
+ NS NS + NS NS + + +
a1–8 Halgren et al., 9–17 Hoyer et al., 18–45 Santen et al. (2013), 46-48 santen et al. (2012), 49 Michelson et al., 50–53 Nagamani et al., 54 Pirola et al., 55 Narahara et al., 56–57 Sukumar et al., 58 Hopkin et al., 59 Meng
et al., 60–64 Tsurusaki et al., 65–70 from decipher database
bThe following abbreviations are used: F female, M male, OFC occipital-frontal circumference, + present, − absent, NA not analyzed, NS not stated, ACC agenesis of corpus callosum, ASD atrial septum defect, trans trans-













ARID1B was the only gene in the region of overlap in-
volving two deletions and one duplication. The two de-
letions were de novo. ARID1B has been identified as
one of the causal genes for Coffin-Siris syndrome and it
has also been associated with syndromic intellectual
disability [10]. While growth retardation was mentioned
as one of the features of Coffin-Sirissyndrome [11], this
feature is currently under appreciated [12]. We then per-
formed a comprehensive case review of the clinical fea-
tures of all individuals carrying mutation in ARID1B
regardless of their associated syndromes (Table 1). This
genotype-driven approach revealed a significant associ-
ation between short stature and mutations in ARID1B.
Next, we further explored the possible contribution of
ARID1B mutations to non-syndromic short stature by
screening 48 short stature patients who did not have
developmental delay or intellectual disability. As a result,
we identified four novel missense variants in ARID1B in-
cluding two de novo variants. The likelihood of a chance
finding of two de novo variants in the same gene in 48 in-
dividuals is extremely small, indicating that these variants
are likely causal of the patients’ short stature. Collectively,
our data support the notion that ARID1B mutations cause
growth retardation in syndromic patients and may also
contribute to non-syndromic short stature.
Coffin-Siris syndrome and short stature
Recently, loss of function mutations in ARID1B were
identified as causative for Coffin-Siris syndrome, a rare
genetic condition characterized by growth deficiency,
developmental delay, severe speech impairment, intel-
lectual disability, and specific physical features includ-
ing microcephaly, coarse facial features, hypertrichosis,
hypoplastic or absent fifth fingernails or toenails and
hypoplasia or agenesis of the corpus callosum [13]. Our
patient A exhibited many features of Coffin-Siris but was
not noted to have hypoplastic or absent fifth fingernails or
toenails. Our patient B showed typical signs of Coffin-Siris
syndrome but not patient C. All three patients exhibited
short stature. We performed a comprehensive review
on published cases with loss-of-function mutations in
ARID1B (Table 1). Based on the available clinical infor-
mation from the published literature, all patients showed
developmental delay (70/70) and language impairment
(63/63). Most of patients exhibited hypertonia (49/56),
seizures (16/52), agenesis of corpus callosum (23/47),
autism or autistic features (9/42) as well as dysmorphic
features: low-set or abnormal-shaped ears (42/47),
prominent nose (41/55), various eye-related fea-
tures (51/64), hypertrichosis (38/51), coarse face/abnor-
mal head shape (16/18), low hair line (9/11), and
spinal/skeletal anomalies (10/12). Patients ascertained
with Coffin-Siris syndrome also exhibited dysplastic
nails.
Case review data showed that 34 % of patients with
ARID1B mutations had short stature defined as height
below -2 SD. The majority (90 %) had a height Z-score
below -1 and none of the patients had above average
height. The average Z score among patients for whom
height data was available is -1.86. Thus, growth retardation
Fig. 2 ARID1B Sanger sequencing data of four patients and their parents
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and short stature is a common feature associated with mu-
tations in ARID1B and Coffin-Siris syndrome.
Coffin-Siris syndrome is a nucleosome remodeling com-
plex (SWI/SNF-SWI) disorder. Mutations in other genes
involved with the SWI/SNF complex such as ARID1A,
SMARCA2, SMARCA4, SMARCB1 and SMARCE1 are
also responsible for Coffin-Siris syndrome [12]. Recent
genotype-phenotype analysis indicated that short stature
is a prominent feature in patients carrying mutations in
those other SWI/SNF genes [14] as well. Among all the
Coffin-Siris syndrome patients detected with mutations in
those BAF-complex-related-genes (BRG1/brm-associated
factor), 21 % of them (9/43) showed short stature. Add-
itionally, 24 % of Coffin-Siris patients without identified
mutations presented with short stature. Thus short stature
is a common feature of Coffin-Siris syndrome.
ARID1B and non-syndromic short stature
We identified four novel missense variants among 48
individuals with idiopathic short stature not associ-
ated with developmental delay. These variants were
not reported in 1000 genomes project database,
dbSNP database, the ESP6500 dataset or ExAC data-
base. Functional predictions suggest deleterious effect
on protein for all four variants, although two of the
variants were found in family members without short
stature. All four variants were absent from 1100 eth-
nically matched controls. We found significantly fewer
deleterious novel missense variants in age, gender,
and ethnicity-matched controls than in short stature
patients. Importantly, two of the variants were de
novo changes not detected in parents and non-
affected siblings. All four patients carrying ARID1B
mutation showed no signs of Coffin-Siris syndrome,
or developmental or mental deficits. ARID1B de novo
mutations have been shown to contribute to the her-
itable complex traits, such as autism spectrum disor-
ders (ASDs), although the effect size may be small
[15]. We have not established the causal relationship
between these mutations and short stature, but we
postulate that ARID1B is also involved with idiopathic
short stature in a similar manner.
Almost all 70 syndromic individuals carried loss-of-
function ARID1B mutations which include genic de-
letions (n = 27), genic duplications (n = 2), nonsense
mutations (n = 14), frame shift mutations (n = 21) and
a translocation (n = 1). On the other hand, all variants
identified in non-syndromic short stature are missense
variants. Based on this finding, we postulate that while
complete loss of the ARID1B gene product causes a
syndrome that involves developmental delay, intellec-
tual disability, dysmorphism and short stature, mis-
sense mutations may cause isolated short stature
without developmental defects. Further testing of more
non-syndromic short stature patient is warranted to
validate such hypothesis.
Conclusions
In order to evaluate the association of ARID1B muta-
tions with syndromic and non-syndromic short stature,
we collected data from a total of 4411 patients who
underwent clinical microarray testing at Boston Chil-
dren’s Hospital, 48 non-syndromic short stature patients
at Shanghai Children’s Medical Center and 70 patients
reported in the literature with ARID1B gene mutations.
By case-control study, retrospective genotype-phenotype
analysis and ARID1B gene mutation screening, we found
haploinsufficient mutations of ARID1B are associated
with syndromic short stature in Coffin-Sirissyndromeor
patients with intellectual disability. ARID1B mutations
are also found to be associated with non-syndromic short
stature. This finding supports the notion that chromatin-
remodeling genes play an important role in human height
regulation.
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